Skip to main content

IGC Pharma, Inc.

IGC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001326205

No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in IGC Pharma, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
35
+7 vs. Q4 2025
Shares held
4.33M
+650.5K (+17.7%) vs. Q4 2025
Total value
$1.14M
+$103.2K (+10.0%) vs. Q4 2025
New holders
11
6 more added
Sold out
4
5 more reduced

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 35 institutions
Q1 2021: 29 institutionsQ2 2021: 29 institutionsQ3 2021: 32 institutionsQ4 2021: 29 institutionsQ1 2022: 29 institutionsQ2 2022: 29 institutionsQ3 2022: 26 institutionsQ4 2022: 26 institutionsQ1 2023: 23 institutionsQ2 2023: 23 institutionsQ3 2023: 27 institutionsQ4 2023: 25 institutionsQ1 2024: 25 institutionsQ2 2024: 25 institutionsQ3 2024: 23 institutionsQ4 2024: 30 institutionsQ1 2025: 25 institutionsQ2 2025: 28 institutionsQ3 2025: 35 institutionsQ4 2025: 30 institutionsQ1 2026: 35 institutionsQ2 2026: 36 institutions
Value heldQ1 2026: $1.14M
Q1 2021: $7.97MQ2 2021: $7.90MQ3 2021: $7.90MQ4 2021: $6.07MQ1 2022: $3.97MQ2 2022: $1.73MQ3 2022: $1.31MQ4 2022: $937.3KQ1 2023: $917.6KQ2 2023: $827.5KQ3 2023: $1.01MQ4 2023: $691.3KQ1 2024: $943.4KQ2 2024: $1.11MQ3 2024: $1.19MQ4 2024: $954.3KQ1 2025: $814.9KQ2 2025: $929.4KQ3 2025: $2.27MQ4 2025: $1.36MQ1 2026: $1.14MQ2 2026: $1.41M
Institutions holding IGC and their total value by quarter
QuarterHoldersValue
Q2 202636$1.41M
Q1 202635$1.14M
Q4 202530$1.36M
Q3 202535$2.27M
Q2 202528$929.4K
Q1 202525$814.9K
Q4 202430$954.3K
Q3 202423$1.19M
Q2 202425$1.11M
Q1 202425$943.4K
Q4 202325$691.3K
Q3 202327$1.01M
Q2 202323$827.5K
Q1 202323$917.6K
Q4 202226$937.3K
Q3 202226$1.31M
Q2 202229$1.73M
Q1 202229$3.97M
Q4 202129$6.07M
Q3 202132$7.90M
Q2 202129$7.90M
Q1 202129$7.97M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q4 2025.

Institutions holding IGC in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Geode Capital Management, LLC1,043,384$274.4K0.00%+182,907+21.3%Added
Vanguard Capital Management LLC718,436$188.9K0.00%+718,436New
BlackRock, Inc.703,798$185.1K0.00%00.0%Unchanged
Renaissance Technologies LLC483,975$127.3K0.00%−435,666−47.4%Reduced
Vanguard Fiduciary Trust Co415,888$109.4K0.00%+415,888New
State Street Corp200,799$52.8K0.00%00.0%Unchanged
Susquehanna International Group, LLP122,595$32.2K0.00%−32,364−20.9%Reduced
Northern Trust Corp113,407$29.8K0.00%00.0%Unchanged
Lawood & Co75,000$19.7K0.02%00.0%Unchanged
Goldman Sachs Group Inc65,541$17.2K0.00%00.0%Unchanged
Dearborn Partners LLC59,401$15.6K0.00%−25,000−29.6%Reduced
XTX Topco Ltd50,648$13.3K0.00%+22,324+78.8%Added
Fisher Asset Management, LLC43,400$11.4K0.00%00.0%Unchanged
Truist Financial Corp36,667$9.64K0.00%00.0%Unchanged
Morgan Stanley35,118$9.24K0.00%+17,411+98.3%Added
Commonwealth Equity Services, LLC33,848$8.90K0.00%+500+1.5%Added
Virtu Financial LLC23,233$6.00K0.00%+23,233New
Tower Research Capital LLC (TRC)21,049$5.54K0.00%+6,657+46.3%Added
T3 Companies, LLC20,000$5.26K0.01%00.0%Unchanged
Vanguard Global Advisers, LLC14,944$3.93K0.00%+14,944New
HighTower Advisors, LLC10,000$2.63K0.00%+10,000New
Schneider Downs Wealth Management Advisors, LP10,000$2.63K0.00%+10,000New
Wealthcare Advisory Partners LLC10,000$2.63K0.00%+10,000New
UBS Group AG8,097$2.13K0.00%−11,772−59.2%Reduced
Trask Adam Roland5,000$1.31K0.00%+5,000New
Group One Trading, L.P.3,762$9890.00%−3,425−47.7%Reduced
Geneos Wealth Management Inc.3,000$7800.00%00.0%Unchanged
CWM, LLC1,000$2630.00%+1,000New
Caitlin John, LLC200$530.00%00.0%Unchanged
Farther Finance Advisors, LLC101$270.00%+1+1.0%Added
Hurley Capital, LLC100$260.00%00.0%Unchanged
DHJJ Financial Advisors, Ltd.80$220.00%00.0%Unchanged
Napier Financial, LLC58$150.00%+58New
Triumph Capital Management2$10.00%00.0%Unchanged
Johnson Financial Group, Inc.1––+1New
Citadel Advisors LLC0$00.00%−277,594−100.0%Sold out
Bank of America Corp0$00.00%−1,808−100.0%Sold out
Jones Financial Companies LLLP0$00.00%−110−100.0%Sold out
Root Financial Partners, LLC0$00.00%−100−100.0%Sold out
Vanguard Group Inc––––Not filed
CIBC Private Wealth Group, LLC––––Not filed